Last Price
1.40
Today's Change
-0.01 (0.70%)
Day's Change
1.33 - 1.41
Trading Volume
327,256
Market Cap
102 Million
Shares Outstanding
73 Million
Latest Quarter
30-Sep-2024 [Q3]
Announcement Date
14-Nov-2024
Reported Currency
USD
Revenue QoQ | YoY
33.29% | 73.60%
NP QoQ | YoY
246.89% | 274.73%
Latest Audited
31-Dec-2023
Announcement Date
14-Mar-2024
Reported Currency
USD
Revenue | Net Profit
65,494,000.00 | 8,312,000.00
EPS | EPS Diluted
0.12 Cent | 0.10 Cent
YoY
155.68%
NP Margin
12.69%
Date | Financial Result (Thousand) | Financial Ratio | Per Share Item | Performance | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP Margin | EPS | EPS Diluted | QoQ | YoY |
PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.
NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.
All figures in '000 unless specified.
Yes, medical startups usually should very very good in everything like that really and totally , yet you do have very low price of the stock here, how can you really even describe this ? Could you damn let me know this please. I am all ears for example.
2019-09-01 13:12
I do hope that medical things will be really our future and not just cause it cause something for example good for now, but in the real perspective for many many generations ahead totally. But for now of course I plan to invest a lot in such things.
2019-09-07 13:56
ysabag
with the new ceo it will raise above the target
2014-07-29 14:51